FDA 483 - Mi3 Limited - August 18, 2022

Mi3 Limited, a medical device manufacturer in Blackburn, Lancashire, was cited for significant quality system deficiencies during an FDA inspection. Observations included inadequate validation of manufacturing equipment and processes, insufficient risk analysis updates for new failure modes, and failures to document the disposition of nonconforming products. Additionally, the firm lacked clear definitions for controlling suppliers and contractors.